<table className="table"><caption><p>Intravenous Antihypertensive Drugs for Treatment of Hypertensive Emergencies</p></caption><thead><tr><th colSpan="1" rowSpan="1"><p>Class</p></th><th colSpan="1" rowSpan="1"><p>Examples</p></th><th colSpan="1" rowSpan="1"><p>Comments</p></th></tr></thead><tbody><tr className="group_1-1 row-odd"><td colSpan="1" rowSpan="1"><p>Dihydropyridine calcium channel blockers</p></td><td colSpan="1" rowSpan="1"><p>Nicardipine</p><p>Clevidipine</p></td><td colSpan="1" rowSpan="1"><p>Nicardipine: contraindicated in patients with severe aortic stenosis</p><p>Clevidipine: contraindicated in patients with severe aortic stenosis, soy allergy, egg allergy, hyperlipidemia, lipoid nephrosis, acute pancreatitis</p></td></tr><tr className="group_1-2 row-even"><td colSpan="1" rowSpan="1"><p>Vasodilator-nitric oxide dependent</p></td><td colSpan="1" rowSpan="1"><p>Sodium nitroprusside</p><p>Nitroglycerin</p></td><td colSpan="1" rowSpan="1"><p>Sodium nitroprusside: intra-arterial blood pressure monitoring recommended. Tachyphylaxis common with prolonged use. Irreversible cyanide toxicity possible with prolonged use.</p><p>Nitroglycerin: Use only for patients with acute coronary syndrome or acute pulmonary edema. Avoid in patients with right ventricular infarction and those taking PDE-5 inhibitors.</p></td></tr><tr className="group_1-3 row-odd"><td colSpan="1" rowSpan="1"><p>Vasodilator-direct</p></td><td colSpan="1" rowSpan="1"><p>Hydralazine</p></td><td colSpan="1" rowSpan="1"><p>Not first-line drug because of unpredictable response and long duration of action</p></td></tr><tr className="group_1-4 row-even"><td colSpan="1" rowSpan="1"><p>Adrenergic blocker-β<sub>1</sub> selective</p></td><td colSpan="1" rowSpan="1"><p>Esmolol</p></td><td colSpan="1" rowSpan="1"><p>Contraindicated with concurrent β-blocker therapy, bradycardia, pulmonary edema, severe heart failure</p></td></tr><tr className="group_1-5 row-odd"><td colSpan="1" rowSpan="1"><p>Adrenergic blocker-combined α<sub>1</sub> and nonselective β-blocker</p></td><td colSpan="1" rowSpan="1"><p>Labetalol</p></td><td colSpan="1" rowSpan="1"><p>Useful in hyperadrenergic syndromes. Contraindicated in patients with asthma, COPD, heart block. May worsen heart failure.</p></td></tr><tr className="group_1-6 row-even"><td colSpan="1" rowSpan="1"><p>Adrenergic blocker-nonselective α-blocker</p></td><td colSpan="1" rowSpan="1"><p>Phentolamine</p></td><td colSpan="1" rowSpan="1"><p>Useful in patients with pheochromocytoma, cocaine toxicity, amphetamine overdose, clonidine withdrawal</p></td></tr><tr className="group_1-7 row-odd"><td colSpan="1" rowSpan="1"><p>ACE inhibitor</p></td><td colSpan="1" rowSpan="1"><p>Enalaprilat</p></td><td colSpan="1" rowSpan="1"><p>Useful in situations associated with high plasma renin activity (scleroderma renal crisis)</p><p>Contraindicated in pregnancy, acute myocardial infarction, bilateral renal artery stenosis</p></td></tr></tbody></table>